
Opinion|Videos|December 19, 2024
Advantages of the Molecular Structure of Aflibercept
Panelists discuss how aflibercept’s molecular structure contributes to its clinical efficacy as a standard treatment for retinal vascular diseases.
Advertisement
Episodes in this series

Video content above is prompted by the following:
- Aflibercept 2 mg is considered the standard of care for retinal vascular diseases. Can you briefly explain the structure of the aflibercept molecule and its significance?
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Ophthalmology Times Europe
1
Synthetic corneal implant shows promise in eyes with chronic corneal oedema
2
Hands-on training, real surgeon input: inside BVI's new Experience Hub
3
Saudi cohort study finds JIA drives most paediatric uveitis cases
4
EuDEC 2026: ectoine eye drops show meaningful symptom and tear film improvements in dry eye disease
5
























